Type a description for this product here... Declaration of ACTIVE substances and other ingredientsASCACID 10%-1l Composition -100 ml suspension contain:Albendazole (methyl carbamate-5n-Propylthio-2-Benzimidazole) 10 g.Excipients: Monopropylglycol, carboximethylcellulose sodium, soda benzoate, demineralised water. IndicationsThe product is indicated in cattle in the treatment of gastrointestinal and pulmonary nematodosis (Ostertagia spp., Nematodirus spp., Haemonchus spp., Trichostongylus spp., Cooperia spp., Dictyocaulus spp., Bunostomum spp., Oesophagostomum spp.) A (Fasciola spp.) and cestodoses (Moniesia spp.). ContraindicationsDue to the potentially teratogenic and embryotoxic effect, it is not given in the first 45 days of gestation. Adverse reactionsThe product is well tolerated in therapeutic dosages. If you notice any severe effects or other effects not listed in this leaflet, notify your veterinarian immediately. Target speciesCattle. posology for each species, the ways and the way of the Ascacid administration 10% is given orally with the syringe or another graduated device for the administration of oral suspensions in animals, in a single dose of 10 mg albendazole/kg body weight (10 ml of ascacid 10%/100 kg body weight).In case of Reinfestation the treatment is repeated after 3 months.In order to ensure proper administration of the therapeutic dose, the body weight of the animal should be determined as accurately as necessary. In the event that several animals are treated once they must be grouped according to their weight and the appropriate dose adjusted to avoid sub-or overdose. Recommendations for proper administrationShake the vial before use. Waiting timeMeat and offal: 28 days.Milk: 3 days. Storage precautionsThe product is stored in a dry, dark place, below 25 °c, protected from frost. Special warningsSpecial warnings for each target species:The following practices increase the risk of resistance development and therefore may cause inefficiency of anthelmintic therapy:Repeated and too frequent use of anthelmintics in the same class for an extited period of time.Sub-dosing, which can be caused by an underestimation of the animal's bodily weight or by improper administration of the product.Suspected clinical cases of antihelmintic resistance should be investigated using paraclinical tests, e.g. the total number of eggs reduction test. In the event that the tests indicate resistance to a certain class of anthelmintics, it should be resorted to an anthelmintic with different mode of action by changing the class. Resistance to Albendazole was reported on Fasciola hepatica, Trichostrongylus spp, Haemonchus spp and Oesophagostomum spp. Therefore, the use of this product should be supported by local (regional, farm-level) epidemiological information about Susceptibility of Fasciola hepatica, Trichostrongylus spp, Haemonchus spp and Oesophagostomum spp and accompanied by recommendations on ways to limit the selection of resistance to albendazole. Use during gestation and lactationDue to the potentially teratogenic and embryotoxic effect, it is not given during the first month of gestation.Interactions with other medicinal products or other forms of interaction.Do not associate with Cimetidine and praziquantel that decrease the absorption of albendazol by modifying the Ph in the rumen. Overdose (symptoms, emergency procedures, antidotes), as appropriate.dose reduction of up to 20 times does not cause any side effects.